{"id":"W4288061296","doi":"10.1200/jco.2022.40.17_suppl.lba5004","title":"Updated overall survival outcomes in ENZAMET (ANZUP 1304), an international, cooperative group trial of enzalutamide in metastatic hormone-sensitive prostate cancer (mHSPC).","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency; University of Alberta; University of British Columbia; Ottawa Hospital","funders":"","keywords":"Medicine; Enzalutamide; Docetaxel; Hazard ratio; Oncology; Internal medicine; Prostate cancer; Cohort; Cancer; Confidence interval; Androgen receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002330751,0.0006330515,0.0006786408,0.000377438,0.0001892787,0.0005925304,0.0005755745,0.0006345985,0.001726438],"category_scores_gemma":[0.002271774,0.0002022222,0.0009968983,0.0003918086,0.000302702,0.0004569876,0.0005209791,0.001124613,0.0001879207],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005862279,"about_ca_system_score_gemma":0.0007466787,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001573202,"about_ca_topic_score_gemma":0.005848932,"domain_scores_codex":[0.9985998,0.001098216,0.00004043119,0.00008453226,0.0001019441,0.00007501939],"domain_scores_gemma":[0.9990084,0.0002043866,0.000441337,0.00007903347,0.00005696907,0.0002099231],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8246363,0.00343499,0.02989989,0.001329577,0.00744693,0.0001255118,0.0001429359,0.003061277,0.004917628,0.0008740214,0.01717115,0.1069597],"study_design_scores_gemma":[0.7287339,0.08963517,0.146695,0.0003747476,0.01096765,0.0003007511,0.00009678139,0.002962012,0.00208662,0.00140977,0.01665359,0.00008395308],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9700223,0.01132064,0.001055669,0.001451671,0.000307891,0.001560962,0.007167445,0.0001187553,0.006994714],"genre_scores_gemma":[0.9777279,0.003034814,0.002121651,0.001643844,0.000207135,0.002569589,0.009380033,0.00002438894,0.003290686],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002330751,"threshold_uncertainty_score":0.01232636,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1627605620197889,"score_gpt":0.515166324359394,"score_spread":0.3524057623396051,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}